Shanthi Ganesh - Concepedia

Author

Shanthi Ganesh

Dicerna Pharmaceuticals (United States)ORCID

Also Known As

Ganesh, S, S GANESH, S Ganesh, S. Alagu Ganesh, S. Ganesh, Shanthi Ganesh, Shanti Ganesh (7987520)

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Dicerna Pharmaceuticals (United States)Research Institute for Genetic and Human Therapy Genesys (United States)Novartis (United States)Northeastern University

About

Shanthi Ganesh is an author at Dicerna Pharmaceuticals (United States) specializing in medicine, tumor biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	896
2	Engineering	4	4	707
3	Health Sciences	1	1	61
4	Natural Sciences	1	1	10
5	Anatomy	1	1	32

Shanthi Ganesh

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors Shanthi Ganesh, Arun K. Iyer, Mansoor M. Amiji Biomaterials NanoparticlesTissue EngineeringNanomedicineCell-based Drug DeliveryEngineering	2013	354
Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study Frans Peters, Shanthi Ganesh, Ernst J. Kuipers, Gut	1999	265
Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers P. Seshidhar Reddy, Kevin D. Burroughs, Laura M. Hales, JNCI Journal of the National Cancer Institute	2007	250
CG0070, a Conditionally Replicating Granulocyte Macrophage Colony-Stimulating Factor–Armed Oncolytic Adenovirus for the Treatment of Bladder Cancer Nagarajan Ramesh, Ying Ge, David L. Ennist, Clinical Cancer Research	2006	234
The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles Dongyu Chen, Shanthi Ganesh, Weimin Wang, Nanoscale NanoparticlesNanomedicineC14 NanoparticlesProtein CoronaEngineering	2019	142
In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles Shanthi Ganesh, Arun K. Iyer, Florence Gattacceca, Journal of Controlled Release Cell-based Drug DeliveryNanomedicineEngineeringTherapeutic NanomaterialsNano-drug Delivery	2013	138
Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer Shanthi Ganesh, Arun K. Iyer, Jan Weiler, Molecular Therapy — Nucleic Acids	2013	133
Development of adenovirus serotype 35 as a gene transfer vector P. Seshidhar Reddy, Shanthi Ganesh, M.Paullin Limbach, Virology Viral ReplicationMedicineGeneticsPathogenesisMolecular Biology	2003	127
The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for<i>in vivo</i>targeted delivery and transfection of oligonucleotides in murine tumor models Dongyu Chen, Neha N. Parayath, Shanthi Ganesh, Nanoscale	2019	123
RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade Shanthi Ganesh, Xue Shui, Kevin P. Craig, Molecular Therapy Antitumor ActivityImmunologyImmunotherapeuticsImmune Cell TherapyImmunotherapy	2018	120

Page 1